Perfuse Therapeutics is conducting trials for the treatment for glaucoma and diabetic retinopathy, aiming to restore vision ...

Glaucoma is the second leading cause of blindness in the U.S.A primary screening tool for glaucoma is measurement of IOP. The ...

Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...

Although there already are "smart" contact lenses that monitor the eyes for signs of glaucoma, the devices are typically only worn when the patient is awake. A new type of contact lens, however, ...

Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with ...

Primary open angle glaucoma and Alzheimer's disease have many similarities in pathophysiology and demographics. Could there be a common mechanisms linking the two diseases?

Decreased Aβ and increased tau in vitreous fluid (glaucoma) and cerebrospinal fluid (Alzheimer's disease) Blennow et al. 53 Nickells, 72 Quigley et al. , 73 Guo et al. 74 and Cordeiro et al. [ 55 ] ...